Clinical trials approved, classified according to the trial area
| Area | No. Clinical Trials |
|---|---|
| ONCOLOGY | 177 |
| VAM | 26 |
| Immunomediated Diseases and Innovative Therapies | 24 |
| NEUROSCIENCES | 16 |
| DIGEST. AND HEPA. DISEASES | 18 |
| INFECTIOUS DISEASES | 14 |
| OTHERS | 12 |
| OBST., PEDIAT. AND GENE | 7 |
| SURGERY RESEARCH | 3 |
| TOTAL | 297 |
Other Studies
| EPA | 32 |
|---|---|
| Medical Device (MD) | 4 |
Clinical trials approved, classified according to the trial phase
| Phase I-II | 151 |
|---|---|
| Phase III | 136 |
| Phase IV | 10 |
| TOTAL | 297 |
Clinical trials classified according to promoter
265 | 89% INDUSTRY
9 | 3%VHIR RESEARCHERS
23 | 8%OTHER HOSPITALS / FOUNDATIONS
Clinical trials according to participants
3 | 1% UNICENTER
294 | 99%MULTICENTER
Clinical trials by HUVH services
| Service | No. Clinical Trials |
|---|---|
| Oncology | 495 |
| Hematology | 117 |
| Neurology | 54 |
| Internal medicine 2-Hep. | 43 |
| Internal medicine 1 | 42 |
| General pediatric | 33 |
| Pediatrics oncohemato. | 28 |
| Neuroinmunology | 27 |
| Pneumology | 25 |
| Infectious | 28 |
| Nephrology | 15 |
| Cardiology | 19 |
| Intensive care | 13 |
| Endocrinology | 13 |
| Traumatology surgery | 9 |
| Oftalmology | 5 |
| Others | 5 |
| Psychiatry | 4 |
| Dermatology | 4 |
| Rehabilitation | 4 |
| Pediatrics nephrology | 3 |
| Anaesthesia | 2 |
| Gynecology | 4 |
| Obstetrics | 4 |
| Plastic / burned | 2 |
| Preventive medicine | 3 |
| Maxillofacial surgery | 2 |
| Digestive | 0 |
| Urology | 2 |
| Neurophisiology | 2 |
| General surgery | 2 |
| Emergency | 2 |
| Radiology | 1 |
| Neonatology | 1 |
| HBP surgery | 1 |
| Pharmacology | 1 |
| TOTAL | 1015 |
Funding evolution, including overheads (M€)
